James Halstead PLC (JHD.L) stock: key figures, P/E, revenue and dividend
Industrials · United Kingdom · ISIN GB00B0LS8535
James Halstead PLC financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 274.00 m GBP | 261.00 m GBP |
| Gross profit | 121.00 m GBP | 116.00 m GBP |
| EBIT | 53.00 m GBP | 52.00 m GBP |
| Net income | 41.00 m GBP | 40.00 m GBP |
| Diluted EPS – continuing operations | 0.10 GBP | 0.10 GBP |
Full history since 1986, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About James Halstead PLC
James Halstead plc manufactures and supplies flooring products for commercial and domestic uses in the United Kingdom, rest of Europe, Scandinavia, Australasia, Asia, and internationally. The company offers its products under the Polyflor, Palettone, Camaro, Polysafe, Recofloor, and Expona names. Its products are used in healthcare, education, and other sectors. James Halstead plc was founded in 1914 and is based in Manchester, the United Kingdom.
More stocks
- Zhejiang Chunhui Intelligent Control Co. Ltd. (300943.SZ)
- Pexip Holding ASA (PEXIP.OL)
- Hangzhou Haoyue Personal Care Co Ltd (605009.SS)
- Alandsbanken Abp (ALBAV.HE)
- Anhui Golden Seed Winery Co Ltd (600199.SS)
- Bowman Consulting Group Ltd. (BWMN)
- Frontier Biopharmaceuticals (Nanjing) Co. Ltd. A (688221.SS)
- Copper Property CTL Pass Through Trust (CPPTL)
- Pason Systems Inc. (PSI.TO)
- Diagnósticos da América S.A (DASA3.SA)
- Shanghai Kaibao Pharmaceutical (300039.SZ)
- WELL Health Technologies Corp (WELL.TO)
Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.